Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORCEPT THERAPEUTICS INC Director's Dealing 2011

May 24, 2011

30681_dirs_2011-05-24_d650df86-78ce-47f6-ab0d-138cd9d00782.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2011-05-19

Reporting Person: LeDoux Anne M (VP & Controller)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-05-19 Stock option (right to buy) $4.42 A 100000 Acquired 2021-05-19 Common Stock (100000) Direct

Footnotes

F1: Exercisable with respect to 2.0834% of the total number of Option Shares on the monthly anniversary of 5/19/2011 each month thereafter.